DUBLIN, Sept. 22, 2015 /PRNewswire/ --
Research and Markets(http://www.researchandmarkets.com/research/nlp5vm/insitu) has announced the addition of the "In-Situ Hybridization Market by Type( DNA,RNA), Application (Cancer Diagnosis, Cytology, Immunology), End User (Hospitals, Pharma & Biotech, Research Labs) & by Geography - Analysis and Forecast to 2019" report to their offering.
The global in-situ hybridization market is estimated at $554.4 Million 2014 and is projected to reach $681.0 Million by 2019, at a CAGR of 4.2% from 2014 to 2019.
This report profiles the major companies operational in the global market, which are Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Affymetrix, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Agilent Technologies, Inc. (U.S.).
On the basis of type, the market has been classified into DNA in-situ hybridization and RNA in-situ hybridization. DNA in-situ hybridization technique led the global market in 2014 and accounted for a market share of 75.4%. This segment is estimated to grow at a CAGR of 4.2% from 2014 to 2019. The DNA and RNA in-situ hybridizations can further be divided into fluorescent in-situ hybridization (FISH) and chromogenic in-situ hybridization (CISH). Amongst these, DNA fluorescent in-situ hybridization (FISH) segment accounted for the largest share of 55.7% in the global market in 2014. It is estimated to grow at a CAGR of 4.0% during the forecast period.
Based on end users, the market has been classified into hospitals, pharma & biotech companies, research labs, and contract research organizations (CROs), where hospital segment accounted for the largest share of 49.6% in the global market in 2014, and is estimated to grow at a CAGR of 4.5% during the forecast period.
Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, and RoW. The in-situ hybridization market in North America contributed the largest share to the global market. The markets in the European and Asia-Pacific regions are expected to grow at CAGRs of 4.3% and 4.7% respectively from 2014 to 2019.
Key Topics Covered:
1 Introduction
2 Executive Summary
3 Market Overview
4 Market Dynamics
5 In-Situ Hybridization Market, By Type
6 In-Situ Hybridization Market, By Application
7 In-Situ Hybridization Market, By End User
8 In-Situ Hybridization Market, By Geography
9 Competitive Landscape
10 Company Profiles
- Abbott
- Advanced Cell Diagnostics
- Affymetrix, Inc.
- Agilent Technologies
- Biogenex
- Biosb
- Exiqon A/S
- F. Hoffmann-La Roche Ltd
- Sigma-Aldrich Co. Llc.
- Thermo Fisher Scientific, Inc.
For more information visit http://www.researchandmarkets.com/research/nlp5vm/insitu
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
